Search details
1.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35443559
2.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Article
in English
| MEDLINE | ID: mdl-36779595
3.
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Haematologica
; 105(5): 1329-1338, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31558669
4.
Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.
Biol Blood Marrow Transplant
; 25(2): 270-278, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30292009
5.
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 25(1): 73-85, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30153491
6.
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(9): 1744-1755, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31158502
7.
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Haematologica
; 106(8): 2295-2296, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-34333962
8.
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Biol Blood Marrow Transplant
; 21(7): 1230-6, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25797175
9.
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 21(2): 266-74, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25445023
10.
Cytarabine dose for acute myeloid leukemia.
N Engl J Med
; 364(11): 1027-36, 2011 Mar 17.
Article
in English
| MEDLINE | ID: mdl-21410371
11.
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia.
Blood
; 118(23): 6037-42, 2011 Dec 01.
Article
in English
| MEDLINE | ID: mdl-21951683
12.
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Blood Adv
; 7(15): 3993-4002, 2023 08 08.
Article
in English
| MEDLINE | ID: mdl-37134306
13.
High-dose daunorubicin in older patients with acute myeloid leukemia.
N Engl J Med
; 361(13): 1235-48, 2009 Sep 24.
Article
in English
| MEDLINE | ID: mdl-19776405
14.
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study.
Blood
; 115(13): 2586-91, 2010 Apr 01.
Article
in English
| MEDLINE | ID: mdl-20103782
15.
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
Transplant Cell Ther
; 28(10): 681-693, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35853610
16.
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
JAMA Oncol
; 8(3): 404-411, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-35024768
17.
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Blood Adv
; 6(3): 828-847, 2022 01 08.
Article
in English
| MEDLINE | ID: mdl-34551064
18.
NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 17(8): 1231-6, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21215810
19.
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
Blood
; 113(6): 1375-82, 2009 Feb 05.
Article
in English
| MEDLINE | ID: mdl-18988865
20.
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
Blood
; 113(13): 3110-8, 2009 Mar 26.
Article
in English
| MEDLINE | ID: mdl-19059878